Xeligekimab

Cat. No. M25113

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

GR 1501

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade.

CAS Number	2382921-73-3
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.

Related IL Receptor/Related Products
IL-17A modulator-2 IL-17A modulator-2 is a IL-17A modulator. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases associated with modulation of IL-17A activity.
IL-15-IN-1 IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM.
IL-17 modulator 3 IL-17 modulator 3 is an IL-17 modulator.
IL-17 modulator 4 IL-17 modulator 4 is a proagent of IL-17 modulator 1. IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator. IL-17 modulator 4 is promising for the research of IL-17A mediated diseases, including inflammation, autoimmune diseases, infectious diseases, cancer, and precancerous syndrome.
IL-17A modulator-3 IL-17A modulator-3 is a IL-17A modulator.

Catalog